Janssen to expand patent case against Juno over generic HIV drug
Intellectual Property 2020-07-01 4:40 pm By Miklos Bolza | Sydney
Please login to bookmark Close

Drug manufacturer Janssen wants to expand its high stakes case against Juno Pharmaceuticals over its HIV drug Prezista, alleging Juno’s plans to launch a generic version of the drug threaten another one of its patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au